Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients

Gastroenterologie Clinique et Biologique

Volumn 20, Issue 11, 1996, Pages 968-971

  Zylberberg, Hervé ^a   Jiang, Jiaji ^a   Pialoux, Gilles ^b   Driss, Françoise ^c   Carnot, Françoise ^c   Dubois, Frédéric ^d   Brechot, Christian ^a   Berthelot, Pierre ^a   Pol, Stanislas ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSTITUT PASTEUR   (France)

^c Hopital Laennec   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

alpha interferon; chronic hepatitis; hepatitis B virus; human immunodeficiency virus; treatment

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; INTERFERON; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE;

ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; FEMALE; HEPATITIS B; HEPATITIS, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0029955945     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rustgi VK, Hoofnagle JH, Gerin JL, Gelmann EP, Reichert CM, Cooper JN, et al. Hepatitis B virus infection in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101: 795-7.
2. Housset C, Pol S, Carnot F, Dubois F, Nalpas B, Housset B, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infection in 260 chronic carriers of hepatitis B virus. Hepatology 1992; 15: 578-83.
3. Scharschmidt BF, Held MJ, Hollander HH, Read AE, Lavine JE, Veereman G, et al. Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival. Ann Intern Med 1992; 117: 837-8.
4. Davis GL. Interferon treatment of viral hepatitis in immunocompromised patients. Semin Liver Dis 1989; 9: 267-72.
5. Pol S, Dubois F, Roingeard P, Zignego L, Housset C, Bréchot C, et al. Hepatitis delta virus infection in French male HBsAg-positive homosexuals. Hepatology 1989; 10: 342-5.
6. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, et al. A randomized, controlled trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 325: 295-301.
7. Dusheiko GM, Di Bisceglie A, Bowyer S, Sacks E, Kew MC. Prolonged recombinant leukocyte interferon treatment of chronic hepatitis B. Hepatology 1985; 5: 556-60.
8. Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, et al. Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95: 1318-25.
9. Perrillo RP, Regenstein FG, Bodicky CJ, Campbell CR, Sanders GE, Sunwoo YC. Comparative efficacy of adenine arabinosine 5′-monophosphate and prednisolone withdrawal followed by adenine arabinoside 5′-monophosphate in the treatment of chronic active hepatitis type B. Gastroenterology 1985; 88:780-6.
10. Weller IV, Lok AS, Mindel A, Karayiannis P, Galpin S, Monjardino J, et al. Randomized controlled trial of adenine arabinoside 5′-monophosphate (ARA-AMP) in chronic hepatitis B infection. Gut 1985; 26: 745-6.
11. Marcellin P, Pialoux G, Girard PM, Boyer N, Martinot-Peignoux M, Loriot MA, et al. Absence of effect of zidovudine on replication of hepatitis B virus in patients with chronic HIV and HBV infection. N Engl J Med 1989; 321: 1758.
12. Pol S, Saltiel C, Legendre C, Carnot F, Driss F, Berthelot P, et al. Efficacy of adenine arabinoside 5′-monosphosphate in kidney recipients with chronic active hepatitis B: a pilot study. Transplant Proc 1993; 25: 1446-9.
13. Horvath J, Raffanti SP. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. Clin Infect Dis 1994; 18: 339-47.
14. Bodsworth N, Donovan B, Nightingale BN. The effect of concurrent human deficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J Infect Dis 1989; 160: 577-82.
15. Fang JWS, Wright TL, Lau JYN. Fibrosing cholestatic hepatitis in patients with HIV and hepatitis B. Lancet 1993; 342; 1175.
16. Benhamou Y, Dahin E, Lunel-Fabiani F, Poynard T, Huraux JM, Katlama C, et al. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet 1995; 345: 396-7.
17. Dienstag JL, Perillo RP, Schiff ER, Bartholome M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995;333:1657-61.